31 related articles for article (PubMed ID: 38677748)
1. Does Lymph Node Status Prior to Neoadjuvant Chemotherapy Influence the Number of Sentinel Nodes Removed?
Baker JL; Muhsen S; Zabor EC; Stempel M; Gemignani ML
Ann Surg Oncol; 2019 Feb; 26(2):336-342. PubMed ID: 30506175
[TBL] [Abstract][Full Text] [Related]
2. De-escalating axillary management after neoadjuvant chemotherapy in breast cancer: The ratio of positive sentinel lymph nodes matters.
Aragón-Sánchez S; Sánchez-Bayona R; López-Marín L; Ciruelos-Gil E; Parrilla-Rubio L; Zaragoza-Ballester P; Galindo-Izquierdo A; García-Chapinal B; Álvaro-Valiente L; Oliver-Pérez MR
Surg Oncol; 2024 Jun; 54():102062. PubMed ID: 38531288
[TBL] [Abstract][Full Text] [Related]
3. Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy.
Weber WP; Hanson SE; Wong DE; Heidinger M; Montagna G; Cafferty FH; Kirby AM; Coles CE
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438776. PubMed ID: 38815195
[TBL] [Abstract][Full Text] [Related]
4. Electrical lymph node scanning (ELS) system for real-time intra-operative detection of involved axillary lymph nodes in adjuvant breast cancer patients.
Abbasvandi F; Mahdavi R; Bayat M; Hajighasemi F; Jahanbakhshi F; Aghaei F; Sami N; Khoundabi B; Ataee H; Yousefpour N; Hoseinpour P; Mousavi Kiasary SMS; Omrani Hashemi M; Shojaeian F; Akbari A; Bagherhosseini N; Moradi A; Akbari ME; Abdolahad M
Sci Rep; 2024 Jun; 14(1):12900. PubMed ID: 38839807
[TBL] [Abstract][Full Text] [Related]
5. The Feasibility and Reliability of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Negative Axillary Lymph Nodes-A Meta-analysis.
Yu M; Liu Y; Huang Z; Zhu Q; Huang Y
Breast Cancer (Auckl); 2024; 18():11782234241255856. PubMed ID: 38826850
[TBL] [Abstract][Full Text] [Related]
6. Controversies in axillary management of patients with breast cancer - updates for 2024.
Tauber N; Bjelic-Radisic V; Thill M; Banys-Paluchowski M
Curr Opin Obstet Gynecol; 2024 Feb; 36(1):51-56. PubMed ID: 37678325
[TBL] [Abstract][Full Text] [Related]
7. Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.
Woodfin AA; Yam C; Teshome M; Kuerer HM; Hunt KK; Meric-Bernstam F; Schaverien M; Barcenas CH; Sun SX
Ann Surg Oncol; 2024 Feb; 31(2):974-980. PubMed ID: 37973647
[TBL] [Abstract][Full Text] [Related]
8. Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma.
Chmiel P; Krotewicz M; Szumera-Ciećkiewicz A; Bartnik E; Czarnecka AM; Rutkowski P
Curr Oncol; 2024 Jan; 31(1):307-323. PubMed ID: 38248105
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity.
Gerashchenko TS; Zavyalova MV; Denisov EV; Krakhmal NV; Pautova DN; Litviakov NV; Vtorushin SV; Cherdyntseva NV; Perelmuter VM
Acta Naturae; 2017; 9(1):56-67. PubMed ID: 28461975
[TBL] [Abstract][Full Text] [Related]
10. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
El Hage Chehade H; Headon H; Kasem A; Mokbel K
Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
[TBL] [Abstract][Full Text] [Related]
11. Incorporating Lymphovenous Anastomosis in Clinically Node-Positive Women Receiving Neoadjuvant Chemotherapy: A Shared Decision-Making Model and Nuanced Approached to the Axilla.
Lustig DB; Temple-Oberle C; Bouchard-Fortier A; Quan ML
Curr Oncol; 2023 Apr; 30(4):4041-4051. PubMed ID: 37185419
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes.
Cipolla C; Lupo S; Grassi N; Battaglia MC; Mesi C; Scandurra G; Gebbia V; Valerio MR
Anticancer Res; 2024 May; 44(5):2047-2053. PubMed ID: 38677748
[TBL] [Abstract][Full Text] [Related]
13. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.
Mamtani A; Barrio AV; King TA; Van Zee KJ; Plitas G; Pilewskie M; El-Tamer M; Gemignani ML; Heerdt AS; Sclafani LM; Sacchini V; Cody HS; Patil S; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3467-3474. PubMed ID: 27160528
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.
Simons JM; van Nijnatten TJA; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef C; Sars PRA; Heijmans HJ; van Haaren ERM; Vles WJ; Contant CME; Menke-Pluijmers MBE; Smit LHM; Kelder W; Boskamp M; Koppert LB; Luiten EJT; Smidt ML
JAMA Surg; 2022 Nov; 157(11):991-999. PubMed ID: 36069889
[TBL] [Abstract][Full Text] [Related]
15. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event.
Barrio AV; Montagna G; Mamtani A; Sevilimedu V; Edelweiss M; Capko D; Cody HS; El-Tamer M; Gemignani ML; Heerdt A; Kirstein L; Moo TA; Pilewskie M; Plitas G; Sacchini V; Sclafani L; Tadros A; Van Zee KJ; Morrow M
JAMA Oncol; 2021 Dec; 7(12):1851-1855. PubMed ID: 34617979
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]